R Squared LTD Argenx Se Transaction History
R Squared LTD
- $181 Billion
- Q2 2025
A detailed history of R Squared LTD transactions in Argenx Se stock. As of the latest transaction made, R Squared LTD holds 980 shares of ARGX stock, worth $659,687. This represents 0.3% of its overall portfolio holdings.
Number of Shares
980
Previous 1,340
26.87%
Holding current value
$659,687
Previous $793 Million
31.89%
% of portfolio
0.3%
Previous 0.85%
Shares
2 transactions
Others Institutions Holding ARGX
# of Institutions
498Shares Held
28.4MCall Options Held
330KPut Options Held
286K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.62 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.88 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.44 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.3 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$831 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $37.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...